Hemas Holdings Q3 2023 Investor Presentation

Hemas Holdings PLC, Sri Lanka's leading conglomerate in consumer and healthcare, presents Q3 FY23 results amid significant macroeconomic headwinds including currency depreciation, inflation, and interest rate pressures. The company, with 75 years of operations and presence in Sri Lanka and Bangladesh, navigates challenging conditions affecting input costs, consumer buying patterns, and working capital requirements.